Parabolic Drugs Ltd. - Research Center
533211 PARABDRUGS Group (Z) BSE data
Add to watchlist
| Results |
Quarterly
|
| Statement | |
| More |
Quarterly results in brief
(Rs crore)
| Sep' 20 | Jun' 20 | Mar' 20 | Jun' 19 | Mar' 19 | |
|---|---|---|---|---|---|
| Sales | - | - | - | - | - |
| Operating profit | - | -1.71 | -1.71 | -1.95 | -1.97 |
| Interest | - | 0.17 | 0.17 | 0.16 | -0.54 |
| Gross profit | -0.01 | -1.88 | -1.88 | -2.10 | -1.42 |
| EPS (Rs) | -0.01 | -1.17 | -1.17 | -1.21 | -1.41 |
Quarterly
results in details
| Sep' 20 | Jun' 20 | Mar' 20 | Jun' 19 | Mar' 19 | |
|---|---|---|---|---|---|
| Other income | - | - | - | 0.01 | 0.01 |
| Stock adjustment | - | - | - | - | 0.59 |
| Raw material | - | - | - | - | -0.27 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | - | 0.42 | 0.42 | 1.09 | 1.34 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | - | 1.29 | 1.29 | 0.86 | 0.31 |
| Provisions made | - | - | - | - | - |
| Depreciation | 0.05 | 5.34 | 5.34 | 5.56 | 5.22 |
| Taxation | - | - | - | -0.17 | 0.18 |
| Net profit / loss | -0.05 | -7.22 | -7.22 | -7.49 | -8.70 |
| Extra ordinary item | - | - | - | - | -1.88 |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 61.89 | 61.89 | 61.89 | 61.89 | 61.89 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | - | - | - | - | - |
| GPM (%) | - | - | - | - | - |
| NPM (%) | - | - | - | - | - |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis